Replies to post #435832 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Look,

I personally dont think that https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6
was offered to NEJM by Liau, Ashkan and Bosch before for the simple reason that NEJM is not particularly fond of publishing interim blinded trials.

Bosch only published 4 times before https://www.biomedcentral.com/search?query=author%23%22Marnix%20L.+Bosch%22 none of them were in NEJM

I cant rule out the account was created prior to submitting the DCVAX L article but I hardly doubt it. So there is no guarantee as with many many posts here as have your posts no guarantee.

Also, Dr Liau probably submitted the article. But the NEJM author-center offers the option to assign co-authors to work on the article together and after. I think that is what happened here.